Microlytic is Ready to Launch its First Product

Danish fledgling firm Microlytic ApS is preparing to enter the equipment market for protein structure determination with a product called Crystal Maker at the "International Conference on the Crystallization of Biological Macromolecules" in Mexico, and seeks further investment capital.

The company aims to gain a 10% slice of the protein structure determination market in three years. Morten Sommer, CEO, says: "The total market is worth about EUR 134 million annually. And it's our hope that Crystal Maker will win widespread acceptance among customers since it has a 30-fold greater success rate than conventional technologies. It is also easy to use and is priced very competitively."

Crystal Maker offers a new way of making protein crystals, which has proved successful in producing better results with greater reliability. Crystallizing proteins is a procedure, which can cause bottlenecks in the process of determining protein structures, and it is here that that Crystal Maker can prove its value.

Microlytic was originally set up with funding from the Danish Ministry of Science and CAT Seed. The company will need further capital to finance scaling up of production and creating a sales organisation. A number of investors are reported to be interested.

For further information please contact:

Morten Sommer,

CEO

Tel: +45 46 74 02 00

Or visit: www.microlytic.com

The official Medicon Valley site is brought to you by the organisations Region Skåne and Copenhagen Capacity - in association with Medicon Valley Alliance

Contact:
Copenhagen Capacity, tel: +45 33 22 02 22
Region Skåne, tel: +46 (0)40 623 97 48


Microlytic is developing microfluidic technology to speed up the structure determination pipeline for crystallographers in industry and academia. Microlytic aims to provide simple, useful and cost effective solutions addressing the crystallization bottleneck in x-ray protein crystallography. The mi...

Read more